Financial Metrics Exploration: Understanding Humana Inc (HUM) Through Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Humana Inc (NYSE: HUM) was $283.14 for the day, down -2.17% from the previous closing price of $289.42. In other words, the price has decreased by -$2.17 from its previous closing price. On the day, 2.03 million shares were traded. HUM stock price reached its highest trading level at $289.0 during the session, while it also had its lowest trading level at $280.46.

Ratios:

Our analysis of HUM’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.68.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 06, 2024, Upgraded its rating to Neutral and sets its target price to $308 from $247 previously.

Bernstein Upgraded its Mkt Perform to Outperform on October 08, 2024, while the target price for the stock was maintained at $308.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 20 ’24 when Mesquita Jorge S. bought 545 shares for $367.09 per share. The transaction valued at 200,066 led to the insider holds 2,578 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 34093172736 and an Enterprise Value of 23381268480. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.07, and their Forward P/E ratio for the next fiscal year is 16.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.99. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 0.203 whereas that against EBITDA is 6.187.

Stock Price History:

Over the past 52 weeks, HUM has reached a high of $527.18, while it has fallen to a 52-week low of $213.31. The 50-Day Moving Average of the stock is 0.05%, while the 200-Day Moving Average is calculated to be -15.43%.

Shares Statistics:

HUM traded an average of 2.27M shares per day over the past three months and 2231770 shares per day over the past ten days. A total of 122.22M shares are outstanding, with a floating share count of 120.11M. Insiders hold about 0.25% of the company’s shares, while institutions hold 97.60% stake in the company. Shares short for HUM as of 1730332800 were 4379317 with a Short Ratio of 1.93, compared to 1727654400 on 2669657. Therefore, it implies a Short% of Shares Outstanding of 4379317 and a Short% of Float of 3.64.

Dividends & Splits

With its trailing 12-month dividend rate of 3.54, HUM has a forward annual dividend rate of 3.54. Against a Trailing Annual Dividend Yield of 0.012231358The stock’s 5-year Average Dividend Yield is 0.71.

Most Popular